Sugammadex Piramal Evropska unija - slovenščina - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskularna blokada - sugamadeks - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Adroiq Evropska unija - slovenščina - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskularna blokada - vsi drugi terapevtski izdelki - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

VENITAN forte 10 mg/100 i.e. v 1 g gela Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

venitan forte 10 mg/100 i.e. v 1 g gela

lek d.d. - escin; natrijev heparinat - gel - escin 10 i.e. / 1 g  natrijev heparinat100 i.e. / 1 g; natrijev heparinat 100 i.e. / 1 g - heparin, kombinacije

Viatromb 2400 i.e./g dermalno pršilo, raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

viatromb 2400 i.e./g dermalno pršilo, raztopina

cyathus exquirere pharmaforschungs gmbh - heparin - dermalno pršilo, raztopina - heparin 2400 i.e. / 1 g - heparin

Viatromb 2400 i.e./g dermalno pršilo, raztopina Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

viatromb 2400 i.e./g dermalno pršilo, raztopina

cyathus exquirere pharmaforschungs gmbh - heparin - dermalno pršilo, raztopina - heparin 2400 i.e. / 1 g - heparin

Hepan 500 i.e./g / 5 mg/g krema Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

hepan 500 i.e./g / 5 mg/g krema

jadran - galenski laboratorij d.d. - dekspantenol; natrijev heparinat - krema - dekspantenol 5 i.e. / 1 g  natrijev heparinat500 i.e. / 1 g; natrijev heparinat 500 i.e. / 1 g - heparin

Hepan 500 i.e./g / 5 mg/g gel Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

hepan 500 i.e./g / 5 mg/g gel

jadran - galenski laboratorij d.d. - dekspantenol, natrijev heparinat - gel - dekspantenol 5 i.e. / 1 g; natrijev heparinat 500 i.e. / 1 g - heparin

VENITAN forte 10 mg/100 i.e. v 1 g gela Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

venitan forte 10 mg/100 i.e. v 1 g gela

lek d.d. - escin, natrijev heparinat - gel - escin 10 mg / 1 g; natrijev heparinat 100 mg / 1 g - heparin, kombinacije

Arixtra Evropska unija - slovenščina - EMA (European Medicines Agency)

arixtra

mylan ire healthcare limited - fondaparinuks natrij - venous thrombosis; pulmonary embolism; myocardial infarction; angina, unstable - antitrombotična sredstva - 5 mg / 0. 3 ml in 2. 5 mg / 0. 5-ml solution for injectionprevention of venous thromboembolic events (vte) in adults undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee surgery or hip-replacement surgery. preprečevanje vte pri odraslih, ki opravljajo abdominalno kirurgijo, ki so presodilo, da je velika verjetnost, thromboembolic zapletov, kot bolnikov, ki abdominalno operacijo raka. preprečevanje vte pri odraslih bolnike, ki so presodilo, da je na visoko tveganje za vte in ki so immobilised zaradi akutne bolezni, kot so srčno insuficienco in / ali akutne dihalne motnje in / ali akutne nalezljive ali vnetnih bolezni. zdravljenje odraslih z akutno simptomatsko spontano površno-venska tromboza spodnjih okončin brez sočasnega globoko vensko trombozo. 5 mg / 0. 5-ml solution for injectiontreatment of unstable angina or non-st-segment-elevation myocardial infarction (ua/nstemi) in adult patients for whom urgent (< 120 mins) invasive management (pci) is not indicated. infarkt (stemi) pri odraslih bolnikih, ki se upravljajo z thrombolytics ali ki sprva so prejeli nobena druga oblika reperfusion terapija. 5 mg / 0. 4-ml, 7. 5 mg / 0. 6-ml in 10 mg/0. 8-ml solution for injectiontreatment of adults with acute deep-vein thrombosis (dvt) and treatment of acute pulmonary embolism (pe), except in haemodynamically unstable patients or patients who require thrombolysis or pulmonary embolectomy.

Rapilysin Evropska unija - slovenščina - EMA (European Medicines Agency)

rapilysin

actavis group ptc ehf - reteplaza - miokardni infarkt - antitrombotična sredstva - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.